These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37287213)

  • 1. Development and physicochemical characterization of a biodegradable microspheres formulation loaded with samarium-153 and doxorubicin for chemo-radioembolization of liver tumours.
    Alregib AH; Tan HY; Wong YH; Kasbollah A; Wong EH; Abdullah BJJ; Perkins AC; Yeong CH
    J Labelled Comp Radiopharm; 2023 Aug; 66(10):308-320. PubMed ID: 37287213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors.
    Wong YH; Tan HY; Kasbollah A; Abdullah BJJ; Acharya RU; Yeong CH
    World J Exp Med; 2020 Mar; 10(2):10-25. PubMed ID: 32266125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of neutron-activated samarium-153-loaded polystyrene microspheres as a potential theranostic agent for hepatic radioembolization.
    Tan HY; Wong YH; Kasbollah A; Md Shah MN; Abdullah BJJ; Perkins AC; Yeong CH
    Nucl Med Commun; 2022 Apr; 43(4):410-422. PubMed ID: 35045548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis.
    Wong YH; Tan HY; Kasbollah A; Abdullah BJJ; Yeong CH
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31718079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic mesoporous embolic microspheres in transcatheter arterial chemoembolization for liver cancer.
    Liu L; Liang X; Xu X; Zhang X; Wen J; Chen K; Su X; Teng Z; Lu G; Xu J
    Acta Biomater; 2021 Aug; 130():374-384. PubMed ID: 34082098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile Preparation of Samarium Carbonate-Polymethacrylate Microspheres as a Neutron-Activatable Radioembolic Agent for Hepatic Radioembolization.
    Wong YH; Kasbollah A; Abdullah BJJ; Yeong CH
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor.
    Lee SY; Choi JW; Lee JY; Kim DD; Kim HC; Cho HJ
    Drug Deliv; 2018 Nov; 25(1):1472-1483. PubMed ID: 29909706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
    Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
    Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities.
    Hashikin NA; Yeong CH; Abdullah BJ; Ng KH; Chung LY; Dahalan R; Perkins AC
    PLoS One; 2015; 10(9):e0138106. PubMed ID: 26382059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monodisperse CaCO
    Chen M; Guo X; Shen L; Ding J; Yu J; Chen X; Wu F; Tu J; Zhao Z; Nakajima M; Song J; Shu G; Ji J
    Int J Biol Macromol; 2023 Mar; 231():123160. PubMed ID: 36610575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional versus drug-eluting embolic transarterial chemoembolization with doxorubicin: comparative drug delivery, pharmacokinetics, and treatment response in a rabbit VX2 tumor model.
    Gaba RC; Khabbaz RC; Muchiri RN; Morrison JD; Elkhadragy L; Totura WM; Samuelson JP; Whiteley HE; Deaton RL; Nguyen PL; Sverdlov M; Johnson JJ; van Breemen RB; Lokken RP
    Drug Deliv Transl Res; 2022 May; 12(5):1105-1117. PubMed ID: 33861419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Tumor-Specific and Long-Acting Iodine-131 Microbeads for Enhanced Treatment of Hepatocellular Carcinoma with Low-Dose Radio-Chemoembolization.
    Qian Y; Liu Q; Li P; Han Y; Zhang J; Xu J; Sun J; Wu A; Song S; Lu W
    ACS Nano; 2021 Feb; 15(2):2933-2946. PubMed ID: 33529007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the spherical integrity for sustained-release alginate microcarriers-encapsulated doxorubicin by the Taguchi method.
    Pan CT; Chien ST; Chiang TC; Yen CK; Wang SY; Wen ZH; Yu CY; Shiue YL
    Sci Rep; 2020 Dec; 10(1):21758. PubMed ID: 33303895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
    AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation and evaluation of ion-exchange porous polyvinyl alcohol microspheres as a potential drug delivery embolization system.
    Li X; Ji X; Chen K; Yuan X; Lei Z; Ullah MW; Xiao J; Yang G
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111889. PubMed ID: 33579501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-based nano-sized drug carrier-containing Gellan gum microspheres as potential multifunctional embolic agent.
    Hsu MF; Tyan YS; Chien YC; Lee MW
    Sci Rep; 2018 Jan; 8(1):731. PubMed ID: 29335649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy.
    Lym JS; Nguyen QV; Ahn da W; Huynh CT; Jae HJ; Kim YI; Lee DS
    Acta Biomater; 2016 Sep; 41():253-63. PubMed ID: 27184404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
    El Fouly A; Ertle J; El Dorry A; Shaker MK; Dechêne A; Abdella H; Mueller S; Barakat E; Lauenstein T; Bockisch A; Gerken G; Schlaak JF
    Liver Int; 2015 Feb; 35(2):627-35. PubMed ID: 25040497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.